Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02869321Phase 4Completed
A Phase 4 trial of fentanyl in breakthrough pain, sponsored by CHRU de Nancy - Hôpital Central. Started May 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02869321.